Shu‐Jin Li
- Topics
- Immunotherapy and Immune Responses (4 papers)Nanoplatforms for cancer theranostics (4 papers)Cancer Immunotherapy and Biomarkers (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Shu‐Jin Li
22 papers receiving 735 citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Biomedical Engineering 316
- Molecular Biology 290
- Immunology 139
- Oncology 133
- Materials Chemistry 121
Countries citing papers authored by Shu‐Jin Li
This map shows the geographic impact of Shu‐Jin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Jin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Jin Li more than expected).
Fields of papers citing papers by Shu‐Jin Li
This network shows the impact of papers produced by Shu‐Jin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Jin Li. The network helps show where Shu‐Jin Li may publish in the future.
Co-authorship network of co-authors of Shu‐Jin Li
This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Jin Li. A scholar is included among the top collaborators of Shu‐Jin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Jin Li. Shu‐Jin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 4 | |
| 4 | 38 | |
| 5 | 16 | |
| 6 | Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapybreakdown → | 143 |
| 7 | 9 | |
| 8 | 13 | |
| 9 | 7 | |
| 10 | 17 | |
| 11 | 144 | |
| 12 | 25 | |
| 13 | 87 | |
| 14 | 54 | |
| 15 | 17 | |
| 16 | 15 | |
| 17 | 51 | |
| 18 | 6 | |
| 19 | 65 | |
| 20 | [Effect of peroxynitrite on the reactivity of rabbit pulmonary arteries in vitro]. | 2 |
About Shu‐Jin Li
Shu‐Jin Li is a scholar working on Immunology, Developmental Neuroscience and Physiology, having authored 22 papers that have together received 742 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Biomaterials (110 citations), Biomedical Engineering (316 citations) and Immunology (139 citations). Shu‐Jin Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhi‐Jun Sun, Qi‐Chao Yang, Zhigang Xu, Shuo Wang, Xianbin Ma, Yuejun Kang, Tian Zhang, Peng Xue, An Song and Jacky W. Y. Lam. Their work appears in journals such as Chemical Society Reviews, Advanced Materials and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.